Artios Pharma
Who owns Artios Pharma?
Artios Pharma is a British Biotech company, currently owned by Sofinnova Partners since 2020 and 3 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Co-held by IP Group, SV Health Managers, Andera Partners and Sofinnova Partners since 2016.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
More from Sofinnova Crossover Fund I
Other portfolio companies in the same fund.
France
United Kingdom· 2026
France· 2021
UK· 2021
Sweden· 2020
Denmark· 2020More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Artios Pharma?
Artios Pharma is currently owned by Sofinnova Partners, Andera Partners and 2 others, through Sofinnova Crossover Fund I, since 2020.
When did Sofinnova Partners and 3 others acquire Artios Pharma?
Sofinnova Partners and 3 others acquired Artios Pharma in 2020.
Who has owned Artios Pharma over time?
Artios Pharma has been through 4 private-equity ownership periods: IP Group · via IP Group (Evergreen) · since 2016; SV Health Managers · via SV Life Sciences Fund VI · since 2016; Andera Partners · via BioDiscovery 5 · since 2018; Sofinnova Partners · via Sofinnova Crossover Fund I · since 2020.